R. Thomas

发表

Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain

M. Atkins, F. Hodi, H. Tawbi, 2018, The New England journal of medicine.

EGFR-targeted intraoperative fluorescence imaging detects high-grade glioma with panitumumab-IRDye800 in a phase 1 clinical trial

N. S. van den Berg, Chirag B. Patel, E. Rosenthal, 2021, Theranostics.

Advances in the management of glioblastoma: the role of temozolomide and MGMT testing

L. Recht, Reena P. Thomas, S. Nagpal, 2012, Clinical pharmacology : advances and applications.

Macrophage Exclusion after Radiation Therapy (MERT): A First in Human Phase I/II Trial using a CXCR4 Inhibitor in Glioblastoma

Robyn L. Ball, L. Recht, D. Born, 2019, Clinical Cancer Research.

Macrophage exclusion after radiation therapy (MERT): A new and effective way to increase the therapeutic ratio of radiotherapy.

L. Recht, Reena P. Thomas, S. Nagpal, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Treatment Options for Optic Pathway Gliomas

L. Recht, I. Gibbs, Reena P. Thomas, 2015, Current Treatment Options in Neurology.

Nodular Leptomeningeal Disease - A Distinct Pattern of Recurrence After Post-Resection Stereotactic Radiosurgery for Brain Metastases: A Multi-Institutional Study of Inter-Observer Reliability.

P. Brown, James D. Murphy, N. Fischbein, 2018, International journal of radiation oncology, biology, physics.

Comparison of Advance Medical Directive Inquiry and Documentation for Hospital Inpatients in Three Medical Services: Implications for Policy Changes

M. Detweiler, J. Detweiler, Roopa Sethi, 2015, Journal of aging & social policy.

Melanoma central nervous system metastases: current approaches, challenges, and opportunities

R. White, P. Wen, P. Brastianos, 2016, Pigment cell & melanoma research.

Phase I study of BPM31510 and vitamin K in patients with high grade glioma recurrent after a bevacizumab-containing regimen.

L. Recht, M. Kiebish, E. Granger, 2020 .

Evaluating Surgical Resection Extent and Adjuvant Therapy in the Management of Gliosarcoma

Steven D Chang, L. Recht, I. Gibbs, 2020, Frontiers in Oncology.

A Phase I/II Trial of 5-Fraction Stereotactic Radiosurgery with 5-mm Margins with Concurrent Temozolomide in Newly Diagnosed Glioblastoma: Primary Outcomes.

Steven D Chang, L. Recht, J. Adler, 2020, Neuro-oncology.

Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life Results.

Steven D Chang, L. Recht, J. Adler, 2017, International journal of radiation oncology, biology, physics.

Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study.

M. Atkins, P. Durani, F. Hodi, 2021, The Lancet. Oncology.

Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204)

M. Atkins, F. Hodi, H. Tawbi, 2021, Neuro-oncology.

Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities

V. Sondak, M. Herlyn, M. Atkins, 2019, Pigment cell & melanoma research.

Efficacy and safety of nivolumab (NIVO) plus ipilimumab (IPI) in patients with melanoma (MEL) metastatic to the brain: Results of the phase II study CheckMate 204.

M. Atkins, F. Hodi, H. Tawbi, 2017 .

Locoregional Radiogenomic Models Capture Gene Expression Heterogeneity in Glioblastoma

Michael, Olivier Gevaert, Daniel L. Rubin, 2018, bioRxiv.

Quantification of Macrophages in High-Grade Gliomas by Using Ferumoxytol-enhanced MRI: A Pilot Study.

A. Gentles, K. Yeom, M. Wintermark, 2019, Radiology.

Radiation Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma: An ASTRO Clinical Practice Guideline.

D. Brat, H. Shih, J. Sheehan, 2022, Practical radiation oncology.

Correction: Macrophage Exclusion after Radiation Therapy (MERT): A First-in-Human Phase I/II Trial using a CXCR4 Inhibitor in Glioblastoma.

L. Recht, Robyn L. Ball, H. Vogel, 2023, Clinical cancer research : an official journal of the American Association for Cancer Research.

Neurological adverse effects due to programmed death 1 (PD-1) inhibitors

Justin M. Moore, Reena P. Thomas, Michael C. Jin, 2020, Journal of Neuro-Oncology.

Phase II pilot study of single-agent etirinotecan pegol (NKTR-102) in bevacizumab-resistant high grade glioma

L. Recht, P. Kunz, Gordon Li, 2015, Journal of Neuro-Oncology.

Response of metastatic glioma to vemurafenib.

L. Recht, H. Vogel, Jennifer L. Ziskin, 2016, Neuro-oncology practice.

A Clinical PET Imaging Tracer ([18F]DASA-23) to Monitor Pyruvate Kinase M2–Induced Glycolytic Reprogramming in Glioblastoma

Chirag B. Patel, L. Recht, G. Davidzon, 2021, Clinical Cancer Research.

Continuous EEG monitoring detects nonconvulsive seizure and Ictal-Interictal Continuum abnormalities in moderate to severe ICANS following systemic CAR-T therapy

K. Graber, D. Miklos, M. Markert, 2022, The Neurohospitalist.

Recurrent Status Epilepticus in the Setting of Chimeric Antigen Receptor (CAR)-T Cell Therapy

D. Miklos, C. Patel, Reena P. Thomas, 2021, The Neurohospitalist.

The incidence and significance of multiple lesions in glioblastoma

R. Lober, Gordon Li, Reena P. Thomas, 2013, Journal of Neuro-Oncology.

Simultaneous Perfusion and Permeability Measurements Using Combined Spin- and Gradient-Echo MRI

Matus Straka, Roland Bammer, Thomas Christen, 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Intracranial Tumor Control Following Immune-Related Adverse Events and Discontinuation of Immunotherapy for Melanoma.

Steven D Chang, S. Hancock, I. Gibbs, 2020, World neurosurgery.